Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,021 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HLA Class I Expression Is Associated with DNA Damage and Immune Cell Infiltration into Dysplastic and Neoplastic Lesions in Ulcerative Colitis.
Okami H, Ozawa N, Sohda M, Yokobori T, Osone K, Erkhem-Ochir B, Dorjkhorloo G, Shiraishi T, Okada T, Sano A, Sakai M, Miyazaki T, Ogawa H, Yao T, Oike T, Sato H, Shirabe K, Shibata A, Saeki H. Okami H, et al. Among authors: sano a. Int J Mol Sci. 2023 Sep 4;24(17):13648. doi: 10.3390/ijms241713648. Int J Mol Sci. 2023. PMID: 37686454 Free PMC article.
MAdCAM-1 targeting strategy can prevent colitic cancer carcinogenesis and progression via suppression of immune cell infiltration and inflammatory signals.
Ozawa N, Yokobori T, Osone K, Bilguun EO, Okami H, Shimoda Y, Shiraishi T, Okada T, Sano A, Sakai M, Sohda M, Miyazaki T, Ide M, Ogawa H, Yao T, Oyama T, Shirabe K, Saeki H. Ozawa N, et al. Among authors: sano a. Int J Cancer. 2024 Jan 15;154(2):359-371. doi: 10.1002/ijc.34722. Epub 2023 Sep 7. Int J Cancer. 2024. PMID: 37676657
Prognostic value of a modified‑immune scoring system in patients with pathological T4 colorectal cancer.
Dorjkhorloo G, Erkhem-Ochir B, Shiraishi T, Sohda M, Okami H, Yamaguchi A, Shioi I, Komine C, Nakazawa N, Ozawa N, Shibasaki Y, Okada T, Osone K, Sano A, Sakai M, Ogawa H, Yokobori T, Shirabe K, Saeki H. Dorjkhorloo G, et al. Among authors: sano a. Oncol Lett. 2024 Jan 17;27(3):104. doi: 10.3892/ol.2024.14237. eCollection 2024 Mar. Oncol Lett. 2024. PMID: 38298428 Free PMC article.
A Mature Tertiary Lymphoid Structure with a Ki-67-Positive Proliferating Germinal Center Is Associated with a Good Prognosis and High Intratumoral Immune Cell Infiltration in Advanced Colorectal Cancer.
Mori N, Dorjkhorloo G, Shiraishi T, Erkhem-Ochir B, Okami H, Yamaguchi A, Shioi I, Komine C, Endo M, Seki T, Hosoi N, Nakazawa N, Shibasaki Y, Okada T, Osone K, Sano A, Sakai M, Sohda M, Yokobori T, Shirabe K, Saeki H. Mori N, et al. Among authors: sano a. Cancers (Basel). 2024 Jul 28;16(15):2684. doi: 10.3390/cancers16152684. Cancers (Basel). 2024. PMID: 39123412 Free PMC article.
Identification of Biomarkers for Assessing Treatment Efficacy of Chemotherapy plus Nivolumab as the First Line in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.
Nakazawa N, Sohda M, Hosoi N, Watanabe T, Kumakura Y, Yamashita T, Tanaka N, Saito K, Kimura A, Kasuga K, Nakazato K, Yoshinari D, Shimizu H, Ubukata Y, Hosaka H, Sano A, Sakai M, Ogawa H, Shirabe K, Saeki H. Nakazawa N, et al. Among authors: sano a. Oncology. 2024 Sep 12:1-8. doi: 10.1159/000540841. Online ahead of print. Oncology. 2024. PMID: 39265540
Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.
Nakazawa N, Sano A, Kumakura Y, Yamashita T, Tanaka N, Saito K, Kimura A, Kasuga K, Nakazato K, Yoshinari D, Shimizu H, Ubukata Y, Hosaka H, Shiraishi T, Sakai M, Sohda M, Shirabe K, Saeki H. Nakazawa N, et al. Among authors: sano a. Oncology. 2024 Oct 24:1-8. doi: 10.1159/000541544. Online ahead of print. Oncology. 2024. PMID: 39447553
Impact of Perioperative Immunonutrition on Postoperative Outcomes for Patients Undergoing Head and Neck or Gastrointestinal Cancer Surgeries: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Matsui R, Sagawa M, Sano A, Sakai M, Hiraoka SI, Tabei I, Imai T, Matsumoto H, Onogawa S, Sonoi N, Nagata S, Ogawa R, Wakiyama S, Miyazaki Y, Kumagai K, Tsutsumi R, Okabayashi T, Uneno Y, Higashibeppu N, Kotani J. Matsui R, et al. Among authors: sano a. Ann Surg. 2024 Mar 1;279(3):419-428. doi: 10.1097/SLA.0000000000006116. Epub 2023 Oct 26. Ann Surg. 2024. PMID: 37882375 Free PMC article.
1,021 results